UCB7362

N/A

Report date: 2022/10/11 17:41:43
NME

Base Information

Drug NameUCB7362
Drug Alias NameUCB7362
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasmepsin X inhibitors
TargetsPlasmepsin X
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUcb Sa
China Registration ClassN/A

Develop Information

Active CompaniesUcb Sa
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A